NovoLog® Mix 70/30 Insulin Treatment


	en Español Important safety information \| Prescribing Information \| Send to a friend \| Glossary

Independence starts here, with NovoLog® Mix 70/30 FlexPen®

If you're looking for a simple way to boost blood glucose control, NovoLog?Mix 70/30 can help. It's one insulin treatment that works in two different ways. It covers your mealtime glucose levels and covers between meals, too. And, most importantly, it's an insulin that your doctor can adjust to your blood glucose needs as they change.

NovoLog?Mix 70/30 helps control your blood glucose by providing insulin coverage right when you need it. This means that while you take it, you won't need any additional insulin. All you'll need is one insulin mix.

Plus NovoLog?Mix 70/30 FlexPen?lets you take your insulin wherever you go, and whenever you need to. FlexPen?offers accurate insulin dosing through an easy-to-use delivery system. It is prefilled and disposable, and can fit in your purse or pocket.

By taking the time to learn more about NovoLog?Mix 70/30 and NovoLog?Mix?70/30 FlexPen? you can feel good knowing that you're taking an important step towards independence with your diabetes treatment.

Indications and Usage for NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]):

NovoLog® Mix 70/30 is a man-made insulin that is used to control high blood sugar in adults with diabetes mellitus.

It is not known if NovoLog® Mix 70/30 is safe or effective in children.

Important Safety Information for NovoLog® Mix 70/30:

Do not take NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or if you are allergic to any of the ingredients in NovoLog® Mix 70/30. If you take too much NovoLog® Mix 70/30, your blood sugar may fall too low (hypoglycemia).

NovoLog® Mix 70/30 starts acting fast. If you have Type 1 diabetes, inject it up to 15 minutes before you eat a meal. If you have Type 2 diabetes, you may inject NovoLog® Mix 70/30 up to 15 minutes before or after starting your meal.

Check your blood sugar levels regularly. Ask your healthcare provider what your blood sugars should be and when you should check your blood sugar levels. Do not make any changes to your dose or type of insulin unless your healthcare provider tells you to. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog® Mix 70/30.

Before using NovoLog® Mix 70/30, tell your health care provider about all medicines you take and all of your medical conditions, including if you have kidney or liver problems or if you are pregnant or breastfeeding. It is not known if NovoLog® Mix 70/30 will harm your unborn baby or pass into breast milk. Your NovoLog® Mix 70/30 dose may change if you take other medicines.

Do not inject NovoLog® Mix 70/30 with any other insulin products or use in an insulin pump.

Do not share needles, insulin pens or syringes with others.

The most common side effects of NovoLog® Mix 70/30 include skin thickening or pits at the injection site (lipodystrophy), weight gain, swelling of your hands and feet, and vision changes. Serious adverse events may include low blood sugar (hypoglycemia), low potassium in your blood (hypokalemia), local allergic reactions at the injection site (like redness, swelling, and itching), and whole body reactions. Get medical help right away if you have any of these symptoms of an allergic reaction: a rash over the whole body, have trouble breathing, fast heart rate, sweating or if you feel faint. Ask your health care provider or pharmacist for more information.

For more information, please click here for complete NovoLog® Mix 70/30 Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Talk to your doctor about the importance of diet and exercise.

If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

FlexPen® NovoFine® and NovoLog® are registered trademarks and Cornerstones4Care^TMis a trademark of Novo Nordisk A/S.

If you do not have Adobe® Reader® you can get it here.